Neuregulin dependent neuronal migration and schizophrenia

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Schizophrenia effects 1-100 Australians and is responsible for $2.2 billion in health costs, disables thought and emotion and is devastating to the individual, the family and the community. We need to develop drugs able to reverse the root cause of schizophrenia. We know that schizophrenia is caused by risk genes and environments and impacts brain maturation. We will test how one such gene, neuregulin, acts to derail the normal development of the human cerebral cortex in patients who suffer.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2011

Funding Scheme: NHMRC Project Grants

Funding Amount: $297,128.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cellular Nervous System

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Genetics | Molecular neuroscience | Neural development | Neuregulin | Neuronal migration | Psychosis | Schizophrenia | Schizophrenia aetiology